Cargando…
Pericardial Effusion due to Infliximab Therapy for Ulcerative Colitis
Ulcerative colitis is characterized by ulcers and inflammation of the inner lining of the gastrointestinal tract. Antitumor necrosis factor alpha (anti-TNF alpha) agents such as infliximab are drugs that have been used for the treatment of ulcerative colitis for decades. Infliximab is known to be as...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6247658/ https://www.ncbi.nlm.nih.gov/pubmed/30533230 http://dx.doi.org/10.1155/2018/4324592 |
_version_ | 1783372526041169920 |
---|---|
author | Mirza, Muhammad Mirza, Maira Murugesan, Vagishwari Olano, Arrel |
author_facet | Mirza, Muhammad Mirza, Maira Murugesan, Vagishwari Olano, Arrel |
author_sort | Mirza, Muhammad |
collection | PubMed |
description | Ulcerative colitis is characterized by ulcers and inflammation of the inner lining of the gastrointestinal tract. Antitumor necrosis factor alpha (anti-TNF alpha) agents such as infliximab are drugs that have been used for the treatment of ulcerative colitis for decades. Infliximab is known to be associated with various adverse effects including anti-TNF alpha induced lupus (ATIL). We present a rare case of a 51-year-old female with pericardial effusion secondary to infliximab therapy for treatment of her ulcerative colitis. Discontinuation of infliximab led to resolution of the pericardial effusion. |
format | Online Article Text |
id | pubmed-6247658 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Hindawi |
record_format | MEDLINE/PubMed |
spelling | pubmed-62476582018-12-09 Pericardial Effusion due to Infliximab Therapy for Ulcerative Colitis Mirza, Muhammad Mirza, Maira Murugesan, Vagishwari Olano, Arrel Case Rep Gastrointest Med Case Report Ulcerative colitis is characterized by ulcers and inflammation of the inner lining of the gastrointestinal tract. Antitumor necrosis factor alpha (anti-TNF alpha) agents such as infliximab are drugs that have been used for the treatment of ulcerative colitis for decades. Infliximab is known to be associated with various adverse effects including anti-TNF alpha induced lupus (ATIL). We present a rare case of a 51-year-old female with pericardial effusion secondary to infliximab therapy for treatment of her ulcerative colitis. Discontinuation of infliximab led to resolution of the pericardial effusion. Hindawi 2018-11-06 /pmc/articles/PMC6247658/ /pubmed/30533230 http://dx.doi.org/10.1155/2018/4324592 Text en Copyright © 2018 Muhammad Mirza et al. https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Case Report Mirza, Muhammad Mirza, Maira Murugesan, Vagishwari Olano, Arrel Pericardial Effusion due to Infliximab Therapy for Ulcerative Colitis |
title | Pericardial Effusion due to Infliximab Therapy for Ulcerative Colitis |
title_full | Pericardial Effusion due to Infliximab Therapy for Ulcerative Colitis |
title_fullStr | Pericardial Effusion due to Infliximab Therapy for Ulcerative Colitis |
title_full_unstemmed | Pericardial Effusion due to Infliximab Therapy for Ulcerative Colitis |
title_short | Pericardial Effusion due to Infliximab Therapy for Ulcerative Colitis |
title_sort | pericardial effusion due to infliximab therapy for ulcerative colitis |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6247658/ https://www.ncbi.nlm.nih.gov/pubmed/30533230 http://dx.doi.org/10.1155/2018/4324592 |
work_keys_str_mv | AT mirzamuhammad pericardialeffusionduetoinfliximabtherapyforulcerativecolitis AT mirzamaira pericardialeffusionduetoinfliximabtherapyforulcerativecolitis AT murugesanvagishwari pericardialeffusionduetoinfliximabtherapyforulcerativecolitis AT olanoarrel pericardialeffusionduetoinfliximabtherapyforulcerativecolitis |